These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27545696)

  • 21. Performance evaluation of Revohem
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
    Int J Lab Hematol; 2019 Oct; 41(5):664-670. PubMed ID: 31271527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat treatment of samples improve the performance of the Nijmegen-Bethesda assay in hemophilia A patients undergoing immune tolerance induction.
    de Lima Montalvão SA; Tucunduva AC; de Almeida Sambo AL; De Paula EV; de Souza Medina S; Ozelo MC
    Thromb Res; 2015 Dec; 136(6):1280-4. PubMed ID: 26344704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Easy Method to Eliminate the Effect of Lupus Anticoagulants in the Coagulation Factor Assay.
    Tang N; Yin S
    Clin Lab; 2016 Jul; 62(7):1363-1365. PubMed ID: 28164630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method.
    Torita S; Suehisa E; Kawasaki T; Toku M; Takeo E; Tomiyama Y; Nishida S; Hidaka Y
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):185-9. PubMed ID: 21245748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External quality assessment of factor VIII inhibitor assays.
    Bonar RA; Favaloro EJ; Marsden K
    Semin Thromb Hemost; 2013 Apr; 39(3):320-6. PubMed ID: 23436565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency estimates for recombinant factor IX in the one-stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagent.
    Wilmot HV; Gray E
    Haemophilia; 2018 Sep; 24(5):e363-e368. PubMed ID: 30051554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B.
    Adcock DM; Strandberg K; Shima M; Marlar RA
    Int J Lab Hematol; 2018 Dec; 40(6):621-629. PubMed ID: 29979821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of different factor VIII inhibitor kinetic profiles on the inhibitor titer quantification using the modified Nijmegen-Bethesda assay.
    Ketteler C; Hoffmann I; Davidson S; Chen D; Tiede A; Richter N
    Res Pract Thromb Haemost; 2022 Nov; 6(8):e12799. PubMed ID: 36518189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.
    Doma SA; Hillarp A; Pajič T; Andoljšek D; Černelč P; Preldžnik Zupan I
    Biochem Med (Zagreb); 2016; 26(2):279-84. PubMed ID: 27346976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
    Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
    Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixing-based inhibitor screening in haemophilia A: challenges in interpretation.
    Arshad S; Awasthi NP; Husain N; Neyaz A; Singh A
    Blood Coagul Fibrinolysis; 2019 Dec; 30(8):401-408. PubMed ID: 31644446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The traceability of commercial plasma calibrators to the plasma International Standards for factor VIII and factor IX.
    Wilmot HV; Rakowski K; Gray E
    Int J Lab Hematol; 2020 Dec; 42(6):810-818. PubMed ID: 32638532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High variability in Factor IX one-stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system.
    Duboscq C; Sueldo E; Rosa C; Zirpoli M; Ceresetto J; Baques A; Arias M
    Int J Lab Hematol; 2024 Feb; 46(1):128-134. PubMed ID: 37704365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of inhibitors in haemophilia. Ongoing epidemiological study.
    Serban M; Mihailov D; Pop L; Ionita H; Ursu E; Talpos-Niculescu S; Ritli L; Baghiu D; Uscatescu V; Petrovanu C; Stancu P; Savescu D; Cucuianu A; Schramm W
    Hamostaseologie; 2011 Nov; 31 Suppl 1():S20-3. PubMed ID: 22057218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity.
    Zhao Y; Feng G; Zhang J; Gong R; Cai C; Feng L
    Sci Rep; 2017 Sep; 7(1):12179. PubMed ID: 28939816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects.
    Favaloro EJ; Gilmore G; Bonar R; Dean E; Arunachalam S; Mohammed S; Baker R
    Haemophilia; 2020 Mar; 26(2):354-362. PubMed ID: 31962376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of sample preheat treatment in a modified Nijmegen-Bethesda assay (mNBA) for inhibitor monitoring in congenital and acquired haemophilia A: A single-centre four-year experience.
    Gandhi T; Lawler P; Foxton E; Chowdary P; Riddell A
    Haemophilia; 2020 Nov; 26(6):e300-e307. PubMed ID: 32892451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.
    Miller CH
    Haemophilia; 2018 Mar; 24(2):186-197. PubMed ID: 29446525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W
    Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.